These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 18346534

  • 1. Role of epidermal growth factor and other growth factors in the prevention of necrotizing enterocolitis.
    Nair RR, Warner BB, Warner BW.
    Semin Perinatol; 2008 Apr; 32(2):107-13. PubMed ID: 18346534
    [Abstract] [Full Text] [Related]

  • 2. Role of epidermal growth factor in the pathogenesis of neonatal necrotizing enterocolitis.
    Warner BW, Warner BB.
    Semin Pediatr Surg; 2005 Aug; 14(3):175-80. PubMed ID: 16084405
    [Abstract] [Full Text] [Related]

  • 3. Heparin-binding EGF-like growth factor (HB-EGF) and necrotizing enterocolitis.
    Feng J, El-Assal ON, Besner GE.
    Semin Pediatr Surg; 2005 Aug; 14(3):167-74. PubMed ID: 16084404
    [Abstract] [Full Text] [Related]

  • 4. Heparin-binding epidermal growth factor-like growth factor decreases the incidence of necrotizing enterocolitis in neonatal rats.
    Feng J, El-Assal ON, Besner GE.
    J Pediatr Surg; 2006 Jan; 41(1):144-9; discussion 144-9. PubMed ID: 16410124
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparison of epidermal growth factor and heparin-binding epidermal growth factor-like growth factor for prevention of experimental necrotizing enterocolitis.
    Dvorak B, Khailova L, Clark JA, Hosseini DM, Arganbright KM, Reynolds CA, Halpern MD.
    J Pediatr Gastroenterol Nutr; 2008 Jul; 47(1):11-8. PubMed ID: 18607263
    [Abstract] [Full Text] [Related]

  • 8. Intestinal barrier failure during experimental necrotizing enterocolitis: protective effect of EGF treatment.
    Clark JA, Doelle SM, Halpern MD, Saunders TA, Holubec H, Dvorak K, Boitano SA, Dvorak B.
    Am J Physiol Gastrointest Liver Physiol; 2006 Nov; 291(5):G938-49. PubMed ID: 16798726
    [Abstract] [Full Text] [Related]

  • 9. Epidermal growth factor reduces the development of necrotizing enterocolitis in a neonatal rat model.
    Dvorak B, Halpern MD, Holubec H, Williams CS, McWilliam DL, Dominguez JA, Stepankova R, Payne CM, McCuskey RS.
    Am J Physiol Gastrointest Liver Physiol; 2002 Jan; 282(1):G156-64. PubMed ID: 11751169
    [Abstract] [Full Text] [Related]

  • 10. Heparin-binding epidermal growth factor-like growth factor promotes enterocyte migration and proliferation in neonatal rats with necrotizing enterocolitis.
    Feng J, Besner GE.
    J Pediatr Surg; 2007 Jan; 42(1):214-20. PubMed ID: 17208569
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Epidermal growth factor reduces hepatic sequelae in experimental necrotizing enterocolitis.
    Halpern MD, Holubec H, Clark JA, Saunders TA, Williams CS, Dvorak K, Dvorak B.
    Biol Neonate; 2006 Jan; 89(4):227-35. PubMed ID: 16319449
    [Abstract] [Full Text] [Related]

  • 13. Understanding the susceptibility of the premature infant to necrotizing enterocolitis (NEC).
    Hunter CJ, Upperman JS, Ford HR, Camerini V.
    Pediatr Res; 2008 Feb; 63(2):117-23. PubMed ID: 18091350
    [Abstract] [Full Text] [Related]

  • 14. Epidermal growth factor reduces intestinal apoptosis in an experimental model of necrotizing enterocolitis.
    Clark JA, Lane RH, Maclennan NK, Holubec H, Dvorakova K, Halpern MD, Williams CS, Payne CM, Dvorak B.
    Am J Physiol Gastrointest Liver Physiol; 2005 Apr; 288(4):G755-62. PubMed ID: 15528252
    [Abstract] [Full Text] [Related]

  • 15. Can we cut the incidence of necrotizing enterocolitis in half--today?
    Christensen RD, Gordon PV, Besner GE.
    Fetal Pediatr Pathol; 2010 Apr; 29(4):185-98. PubMed ID: 20594142
    [Abstract] [Full Text] [Related]

  • 16. Molecular signaling in necrotizing enterocolitis: regulation of intestinal COX-2 expression.
    Lugo B, Ford HR, Grishin A.
    J Pediatr Surg; 2007 Jul; 42(7):1165-71. PubMed ID: 17618875
    [Abstract] [Full Text] [Related]

  • 17. Probiotic and prebiotic supplementation for the prevention of neonatal necrotizing enterocolitis.
    Caplan MS.
    J Perinatol; 2009 May; 29 Suppl 2():S2-6. PubMed ID: 19399005
    [Abstract] [Full Text] [Related]

  • 18. Neonatal inflammatory intestinal diseases: necrotising enterocolitis and allergic colitis.
    Fell JM.
    Early Hum Dev; 2005 Jan; 81(1):117-22. PubMed ID: 15707723
    [Abstract] [Full Text] [Related]

  • 19. Necrotizing enterocolitis--bench to bedside: novel and emerging strategies.
    Guner YS, Chokshi N, Petrosyan M, Upperman JS, Ford HR, Grikscheit TC.
    Semin Pediatr Surg; 2008 Nov; 17(4):255-65. PubMed ID: 19019294
    [Abstract] [Full Text] [Related]

  • 20. Probiotics: role in pathophysiology and prevention in necrotizing enterocolitis.
    Martin CR, Walker WA.
    Semin Perinatol; 2008 Apr; 32(2):127-37. PubMed ID: 18346537
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.